Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation

We evaluated the impact of light chain type, lambda (λ) or kappa (κ), on disease features and outcomes in patients with immunoglobulin light chain (AL) amyloidosis receiving stem cell transplant at the Mayo Clinic between October 2002 and August 2016. Patients with λ AL amyloidosis had higher rates...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood Adv
Главные авторы: Sidiqi, M Hasib, Aljama, Mohammed A., Muchtar, Eli, Buadi, Francis K., Warsame, Rahma, Lacy, Martha Q., Dispenzieri, Angela, Dingli, David, Leung, Nelson, Gonsalves, Wilson I., Kumar, Shaji K., Kapoor, Prashant, Kourelis, Taxiarchis V., Hogan, William J., Gertz, Morie A.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2018
Предметы:
Clinical Trials and Observations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5894263/
https://ncbi.nlm.nih.gov/pubmed/29615413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018016782
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы